Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Board Review
CME
Careers
Cases
Conferences
Videos
Webinars
Podcasts
Advertising
Buyer's Guide
Vendors
Minnies
Resources: Page 286
SPECT/CT can aid lymphoscintigraphy for sentinel nodes
By
Wayne Forrest
Thursday, December 3 | 11:20 a.m.-11:30 a.m. | SSQ15-06 | Room S505ABSPECT/CT can complement planar lymphoscintigraphy to depict unseen sentinel nodes in patients with invasive breast cancer, according to this study from the Netherlands.
November 11, 2015
Is PET/MRI best for evaluating myocardial ischemia?
By
Wayne Forrest
Thursday, December 3 | 11:00 a.m.-11:10 a.m. | SSQ02-04 | Room S502ABIn this presentation, a group from Washington University in St. Louis will detail the benefits of perfusion PET/MRI for comprehensive myocardial ischemic evaluation.
November 11, 2015
FDG-PET/CT can help find hidden infections
By
Wayne Forrest
Wednesday, December 2 | 3:40 p.m.-3:50 p.m. | SSM14-05 | Room S504CDIn this afternoon session, researchers from India will discuss FDG-PET/CT's usefulness for detecting hidden infections, which can cause pyrexia, or an increase in body temperature.
November 11, 2015
Time-of-flight PET/MRI takes off with cardiac sarcoidosis
By
Wayne Forrest
Wednesday, December 2 | 3:30 p.m.-3:40 p.m. | SSM14-04 | Room S504CDSimultaneous cardiac PET/MRI is getting the thumbs up from researchers who found that the hybrid modality produces diagnostic-quality images with less radiation dose than PET/CT.
November 11, 2015
PET/CT could predict cardiac sarcoidosis outcomes
By
Wayne Forrest
Wednesday, December 2 | 3:10 p.m.-3:20 p.m. | SSM16-02 | Room S505ABIn this study, researchers used PET/CT perfusion to predict the risk of poor outcomes among patients with cardiac sarcoidosis.
November 11, 2015
FDG-PET/MRI study breaks ground in rare inflammatory condition
By
Wayne Forrest
Wednesday, December 2 | 3:10 p.m.-3:20 p.m. | SSM14-02 | Room S504CDAnother group from Germany is reporting promising results of FDG-PET/MRI for idiopathic retroperitoneal fibrosis, a rare inflammatory condition in which a fibrotic mass surrounds the abdominal aorta and can cause severe complications, such as renal failure.
November 11, 2015
Bone mets no match for hybrid 3D hot-spot analysis of PET/CT
By
Eric Barnes
Wednesday, December 2 | 12:45 p.m.-1:15 p.m.| NM223-SD-WEB11 | Room S503ABA technique that identifies bone metastasis "hot spots" automatically from PET/CT could vastly improve radiologists' ability to diagnose and follow-up patients with bone cancer.
November 11, 2015
PET/MRI lends a hand in challenging cervical cancer cases
By
Wayne Forrest
Wednesday, December 2 | 10:40 a.m.-10:50 a.m. | SSK14-02 | Room N229A new German study has added to the evidence that PET/MRI can be a valuable resource in oncology applications, especially in difficult-to-diagnose cases.
November 11, 2015
Mayo Clinic study shows advantages of MBI
By
Wayne Forrest
Tuesday, December 1 | 3:40 p.m.-3:50 p.m. | SSJ02-05 | Room E450AResearchers from the Mayo Clinic in Rochester, MN, have concluded that molecular breast imaging (MBI) may be a better option than breast-specific gamma imaging, especially for low-dose breast imaging.
November 11, 2015
PEM device receives kudos from Dutch researchers
By
Wayne Forrest
Tuesday, December 1 | 3:10 p.m.-3:20 p.m. | SSJ02-02 | Room E450AA Spanish company's positron emission mammography (PEM) system is drawing positive reviews from Dutch researchers, who will share their thoughts in this afternoon session.
November 11, 2015
Study explores PET/CT parameters to predict NSCLC outcomes
By
Wayne Forrest
Tuesday, December 1 | 3:00 p.m.-3:10 p.m. | SSJ17-01 | Room S505ABPretreatment volumetric PET/CT parameters, such as metabolic tumor volume and total lesion glycolysis, are strong predictors of overall survival for patients with non-small cell lung cancer (NSCLC), according to this study to be presented on Tuesday afternoon.
November 11, 2015
Ga-68 PSMA PET/CT proves valuable for prostate cancer
By
Wayne Forrest
Tuesday, December 1 | 3:00 p.m.-3:10 p.m. | SSJ14-01 | Room S504CDGallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/CT is accurate for staging and restaging patients with prostate cancer, according to this paper from Mumbai, India.
November 11, 2015
Previous Page
Page 286 of 726
Next Page